Detecting 6-monoacetylmorphine, or 6-MAM, can strengthen the identification of heroin exposure when morphine and codeine alone leave the exposure history less clear. That identification is different from proving that heroin caused death. Brunet and Mura’s own laboratory case illustrates both the value and the interpretive limit of vitreous testing.
What did the blood show?
The authors described a young woman whose death was suspected to involve heroin overdose. Cardiac blood contained morphine at 328 ng/mL and codeine at 64 ng/mL. They considered those blood findings insufficient by themselves to conclude formally that an overdose had occurred.
The account did not provide the woman’s exact age, a precisely known ingestion time, a death-to-collection interval or a detailed storage history. The blood specimen was described as cardiac; it should not be substituted for a specified peripheral vessel.
What did the eye specimen add?
Vitreous contained 6-MAM at 42 ng/mL, morphine at 118 ng/mL and codeine at 68 ng/mL. These were three analytes in one alternative specimen, not three independent deaths or repeated measurements establishing a time course.
The 6-MAM finding added heroin-related metabolic evidence beyond morphine and codeine concentrations. The authors treated the combined findings as supporting the suspected heroin-overdose interpretation. The case nevertheless supplied no independent diagnostic experiment validating a fatal vitreous 6-MAM threshold.
The report did not give a numerical blood 6-MAM result for this individual. It is therefore inappropriate to turn an unreported value into zero, describe a validated negative blood result, or calculate a blood-to-vitreous 6-MAM ratio for her.
Method details supported a defined analytical finding
The laboratory’s opiate procedure used solid-phase extraction and LC–MS/MS. Drug-negative vitreous supplied matrix-matched calibration, and specimens were centrifuged before analysis. The investigators applied their routine plasma procedures to vitreous.
The report did not reproduce analyte-specific vitreous detection and quantitation limits, precision or recovery for the case. LC–MS/MS is an analytical technology; naming it does not independently establish every element of identification or quantitative performance in a different matrix.
The morphine and codeine relationships were not universal rules
In this case, the vitreous/blood quotient was approximately 0.36 for morphine and 1.06 for codeine. These calculations use the reported concentrations and show that the two opiates had different compartment relationships.
One compatible pair cannot establish a fixed conversion for either drug. It also does not prove the absence of postmortem change or tell the reviewer what the circulating concentrations were before death.
A ratio between two postmortem specimens is a different observation from a serial comparison in the same person. The study provided no paired predeath sample against which to measure change.
What can be concluded responsibly?
Keep exposure identity, quantitative magnitude and causal attribution separate. The vitreous 6-MAM finding supported heroin identification in the investigated case. It did not determine an administered dose, a precise last-use time, earlier impairment or an infallible boundary between fatal and nonfatal exposure.
In a new investigation, the complete autopsy, clinical and scene records, co-detected drugs and actual laboratory validation must accompany the result. The limitations of vitreous screening compared with blood remain relevant: specimen utility must be assessed for the particular analyte and procedure.
Primary source
Brunet B, Mura P. L’humeur vitrée en toxicologie médico-légale : revue de la littérature et applications [Vitreous humor as an alternative matrix in forensic toxicology: literature review and applications]. Annales de Toxicologie Analytique. 2012;24(1):9–15. doi:10.1051/ata/2012004. The case findings discussed here are the authors’ own laboratory observations within this review-and-applications paper.
Leave a Reply